Oncolytics Biotech Inc T.ONC

Alternate Symbol(s): ONCY

Healthcare Biotechnology

Oncolytics Biotech Inc. is a clinical-stage biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and adaptive immune responses to treat a variety of cancers. This improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The Company’s primary focus is to advance its programs in hormone receptor-positive / human epidermal growth factor 2- negative (HR+/HER2-) metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma to registration-enabling clinical studies. In addition, it is exploring opportunities for registrational programs in other gastrointestinal cancers through its GOBLET platform study.

TSX:ONC - Post by User

Oncolytics Biotech Inc > Could be a big week for SAVA

<< Previous

Bullboard Posts

Next >>

Post by HCallahann44on Nov 27, 2022 2:40pm

290 Views

Post# 35132197

Could be a big week for SAVA

this is the stock we were all looking for when we bought ONCY.....if the studies hold with SAVA...and the drug moves forward...the price projections are silly....1500 - 5000 a share? If oncy would get to my break even i will dump my whole position into sava....and be glad never to hear the nonsense from noteable and canada again

<< Previous

Bullboard Posts

Next >>

Pro Women’s Hockey League comes to NHL 25 in December